Morristown, NJ, 18 August 2009 – An H1N1 influenza channel has been added to the Elsevier Global Medical News (EGMN) wire service division of the International Medical News Group. The H1N1 channel was created to meet physicians' continuing needs to keep up-to-date with the news about the spread of the 2009 H1N1 influenza virus, as well as the new diagnostics, vaccines, clinical trials, and treatments for H1N1 infections.
"Rapid dissemination of H1N1 news will be essential to physicians during this pandemic. EGMN wants to assure its clients that physicians will look to them for the latest H1N1 developments," said Alan Imhoff, president and publisher of the International Medical News Group.
Elsevier Global Medical News is the daily syndicated medical news wire service of the International Medical News Group (IMNG), which has a 40-year history of success in providing medical specialty news. The EGMN division was launched in January 2006 and its syndicated news now appears in 30 countries as part of its clients' websites and intranet and is the medical specialty news provider to Elsevier's MDConsult, MedConnect, and OncologySTAT. Offering original news written for physicians and divided into therapeutic areas or "channels," EGMN is produced by more than 60 journalists with on-site reporting from over 450 medical meetings, breaking news, journal summaries, and feature stories from medical experts.
EGMN's H1N1 news content is also available on the Lancet's H1N1 site, www.thelancet.com/H1N1-flu. The Lancet's H1N1 Resource Centre is the result of a collaborative effort by the editors of over 40 Elsevier-published journals and 11 learned societies who have agreed to make freely available on this site any relevant content.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).